Antares Pharma reviews total revenue of $4.7 million for fourth quarter 2013 Antares Pharma, Inc. today reported operating and economic results for the fourth quarter and full year ended December 31, 2013 silagra uk http://silagra-rx.com . Recent Highlights Received acceptance of OTREXUP injection by the U.S. Food and Medication Administration . OTREXUP is the initial FDA approved subcutaneous methotrexate for once weekly self-administration with an easy-to-use, single dose, disposable auto injector. OTREXUP premiered to rheumatologists in January 2014.
.. Anthrax, brucellosis and bovine TB fail to receive official recognition, say researchers Decades of neglect have allowed infectious illnesses to devastate the lives of a large number of people in the developing world, a study reveals. Experts say three diseases specifically – anthrax, brucellosis and bovine tuberculosis – have didn’t receive the official financing and recognition had a need to combat them effectively. All three effect on human and pet health in developing countries greatly, posing a major risk to plentiful and safe food supplies. The disorders – referred to as zoonotic diseases – are spread between pets and humans.